Sagimet Biosciences (NASDAQ:SGMT) used a presentation at Guggenheim’s Emerging Outlook Conference to highlight its strategy of targeting fatty acid synthase (FASN) across metabolic and dermatologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results